Rising costs, unpredictable policies, and dwindling incentives are forcing Big Pharma to rethink the UK, with leading firms pausing multi-million-pound R&D projects, but why is the country losing its competitive edge?
Recent data published by the UK’s independent medicines regulator assures the Pfizer/BioNTech and the Oxford University/AstraZeneca vaccines meet strict regulatory standards for safety
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains why hemp protein is gaining a reputation as nutraceutical product.
CBD oil has long been utilised for its various therapeutic effects, but what about its effect on cancer? Read on to find out more about what the research shows.
Dr Andrew McIndoe MBE & Dr Ed Hammond MBE chart the rapid and successful adaptation of delivery of a national teaching programme to the COVID-19 pandemic.
Aida Batista, Vice President of the European Association of Hospital Pharmacists (EAHP), explores if we can live without pharmacology, including comment on the use of opioid and sedative drugs.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Pfizer/BioNTech COVID-19 vaccine for use in the UK and will be made available as early as next week.
